Chapter 58 SELECTED REFERENCES Crawford P, Zimmermann EE. Differentiation and diagnosis of tremor. Am Fam Physician. 2011; 83(6):697–702. Fritsch T, Smyth KA, Wallendal MS, et al. Parkinson disease: research update and clinical management. South Med J. 2012;105(12):650–656. Gazewood JD, Richards DR, Clebak K. Parkinson disease: an update. Am Fam Physician. 2013; 87(4): 267–273. Jankovic J, Poewe W. Therapies in Parkinson’s disease. Curr Opin Neurol. 2012;25:433–447. Rao SS, Hofmann LA, Shakil A. Parkinson’s disease: diagnosis and treatment. Am Fam Physician. 2006;74: 2046–2054, 2055–2056. Worth PF. How to treat Parkinson’s disease in 2013. Clin Med. 2013;13(1):93–96. Yaman A, Yaman H. How best to address these common movement disorders. J Fam Pract. 2011; 60(12):721–725. Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of Quality Standards Subcommittee of the American Neurology. Neurology. 2011;77: 1752–1755. Online only REFERENCES Clarke CE, Moorre AP. Parkinson’s disease. Clin Evid. 2007;08:1203. Emre M. Nöroloji Temel Kitabı (Book of Basic Neurology). Ankara, Turkey: Güneş Publishing; 2013. Ferreira J, Sampaio C. Essential tremor. Clin Evid. 2007;05:1206. Leehey MA. Tremor: diagnosis and treatment. Primary Care Case Rev. 2001;4:34. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord. 2010;25(5):534–541. Pahwa R, Lyons KE, Wilkinson SB, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006;104:506–512. Smaga S. Tremor. Am Fam Physician. 2003;68:1545–1552, 1553. Smith Y, Wichmann T, Factor SA, DeLong MR. Parkinson’s disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharm Rev. 2012;37:213–246.